Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-042311

Chief Executive Officer sold 58,400 shares at an average $40.00 ($2,335,739)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ciechanover Isaac E. Chief Executive Officer 2018-07-09 Sale −27,859 $39.88 $1,111,017 128,219 I: show line 1 in the form
Ciechanover Isaac E. Chief Executive Officer 2018-07-09 Sale −2,141 $40.63 $86,989 126,078 I: show line 2 in the form
Ciechanover Isaac E. Chief Executive Officer 2018-07-10 Sale −22,300 $39.93 $890,439 103,778 I: show line 3 in the form
Ciechanover Isaac E. Chief Executive Officer 2018-07-10 Sale −6,100 $40.54 $247,294 97,678 I: show line 4 in the form
Open-market sales · 58,400 sh · avg $40.00 · $2,335,739
Loading xslF345X03/doc4.xml…